Stay updated on Pembrolizumab in MSI Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA minor update to the ClinicalTrials.gov interface version is reflected in the page footer, moving from revision v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 deleted.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page history.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded revision v3.4.3 to the history and removed revision v3.4.2.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page history shows a new revision (v3.4.2) and removal of the previous revision (v3.4.1), indicating a minor platform update with no visible changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check100 days agoChange DetectedA new revision tag, v3.4.1, was added to the history, replacing v3.4.0, which is a minor update with no changes to study data or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.